checkAd

    Unveiling the Future of Drug Testing  145  0 Kommentare Psychemedics Introduces Advanced 5-Panel Drug Screen - Seite 2

    About Psychemedics 

    Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

    Cautionary Statement for purposes of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995: 

    From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties. In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning earnings, earnings per share, revenues, cash flows, receivables collection dates, dividends, future business, growth opportunities, new or revised product offerings (including the Company’s Advanced 5-panel drug screen) profitability, pricing, new accounts, customer base, market share, test volume, sales and marketing strategies, market demand for drug testing services, and new test development, may be “forward-looking” statements. Actual results may differ from those stated in any forward-looking statements. Factors that may cause such differences include but are not limited to, changes in U.S. and foreign government regulations, including but not limited to FDA regulations, currency risks, R&D spending, competition (including, without limitation, competition from other companies pursuing the same growth opportunities), the Company’s ability to maintain its reputation and brand image, the ability of the Company to achieve its business plans, cost controls, leveraging of its global operating platform, risks of information technology system failures and data security breaches, the uncertain global economy, the Company’s ability to attract, develop and retain executives and other qualified employees and independent contractors, including distributors, the Company’s ability to obtain and protect intellectual property rights, litigation risks, general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission. The forward-looking statements contained herein speak only of the Company's expectations as of the date of this press release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in the Company's expectations or any change in events, conditions, or circumstances on which any such statement is based.

    Seite 2 von 3


    Aktuelle Themen


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Unveiling the Future of Drug Testing Psychemedics Introduces Advanced 5-Panel Drug Screen - Seite 2 Psychemedics’ FDA-cleared alternative 5-panel drug screen replaces marijuana with fentanyl.ACTON, Mass., Oct. 27, 2023 (GLOBE NEWSWIRE) - In an era marked by relentless change and the pressing need to adapt, Psychemedics, a pioneer in the drug …

    Schreibe Deinen Kommentar

    Disclaimer